International Journal of Dental Sciences & Research - Volumes & Issues - Volume 1: Dec 2021, Issue 2

Trigeminal neuralgia – a comprehensive clinical review

  • Published: Dec 2021
Download PDF
Google Scholar

Authors

Dr Prabha Choudhary, Dr Santokh Singh, Dr Chandan Choudhary, Dr Rajni Bala, Dr Meetika, Dr Richa Sehgal

DOI Number

–

Keywords

Trigeminal Neuralgia

Abstract

Trigeminal Neuralgia, also known as Tic douloureux, is a chronic neuropathic pain associated with the fi h cranial nerve (Trigeminal nerve) which carries sensations from the face to brain and some of the motor functions like bi ng and chewing. The aim of this review paper was to determine the current aspects about trigeminal neuralgia including its classification, etiology, diagnosis, and treatment options. The review was conducted using previous research, review, and case studies. The average onset for trigeminal neuralgia is between 50-70 years, although can be found in younger age too. A complete and thorough history is the most important diagnosis tool as well as for prognosis of the disease. Though vascular compression induced morphologic changes in the nerve being the most common cause of trigeminal neuralgia, other variants of its clinical phenotype and etiological factors must also be considered. New MRI methods have helped in proper diagnosis, providing insight about the TN pathogenesis and prognosis. Various new drugs have promising results though more larger scale studies are required. Microvascular decompression is the major and widely accepted method for long lasting pain relief in trigeminal neuralgia

References

  1. Wu S, Lian Y, Zhang H, Chen Y, Wu C, et al. Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect, Original Research. Journal of Pain Research 2019: 12 2177-2186.
  2. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. CEPHALALGIA. 2018; 38:1-211.
  3. Krafft RM. Trigeminal neuralgia. Am Fam Physician. 2008;77: 1291–6.
  4. McMillan R. Trigeminal Neuralgia – a debilitating facial pain. Rev pain SAGE Publications; 2011; 5:26–34.
  5. Jones Mark R., Uritis Ivan, Ehrhardt Ken P., et al. A comprehensive review of trigeminal neuralgia; Current Pain and Headache (2019) 23:74
  6. Maarbjerg S, Gozalov A, Olesen J, Bendtsen L. Trigeminal neuralgia–a prospective systematic study of clinical characteristics in 158 patients. Headache. 2014; 54:1574–82.
  7. Arifin Andrew J., Lam Selay, MacNeil S. Danielle, A case report of primary lymphoma of the tongue presenting as trigeminal neuralgia: Case Report; Arifin et al Journal of Otolaryngology- Head and Neck Surgery 2019 48:37.
  8. Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F. Advances in diagnosis and treatment of trigeminal neuralgia. Ther Clin Risk Manag. 2015; 11:289–99 A review of advances in management of TN.
  9. Tai Alexander X., Nayar Vikram V., Update on trigeminal neuralgia, Curr Treat Options Neurol (2019) 21:42
  10. Cruccu Giorgio, Finnerup Nanna B., et al., Trigeminal neuralgia -New classification and diagnostic grading for practice and research. Neurology.2016 Jul 12; 87(2): 220–228.
  11. Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008; 71:1183–1190.
  12. Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. AANEFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008; 15(10):1013–28.
  13. Bope ET, Kellerman RD, Conn HF (Howard F. Conn’s current therapy 2016.
  14. Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies: 2008 Oct 7;71(15):1183-90.
  15. Antonini G, Di Pasquale A, Cruccu G, et al. Magnetic resonance imaging contribution for diagnosing symptomatic neurovascular contact in classical trigeminal neuralgia: a blinded case-control study and meta-analysis. Pain 2014; 155:1464–1471.
  16. Gonella MC, Fischbein NJ, So YT. Disorders of the trigeminal system. Semin Neurol. 2009;29(1):36–44.
  17. Leal PR, Barbier C, Hermier M, Souza MA, Cristino Filho G, Sindou M. Atrophic changes in the trigeminal nerves of patients with trigeminal neuralgia due to neurovascular compression and their association with the severity of compression and clinical outcomes. J Neurosurg 2014; 120:1484–1495.
  18. Sarsam Z, Garcia-Finana M, Nurmikko TJ, Varma TR, Eldridge P. The long-term outcome of microvascular decompression for trigeminal neuralgia. Br J Neurosurg 2010; 24:18–25.
  19. Leal PR, Hermier M, Souza MA, Cristino-Filho G, Froment JC, Sindou M. Visualization of vascular compression of the trigeminal nerve with high-resolution 3T MRI: a prospective study comparing preoperative imaging analysis to surgical findings in 40 consecutive patients who underwent microvascular decompression for trigeminal neuralgia. Neurosurgery 2011; 69:15–25.
  20. Shimizu M, Imai H, Kagoshima K, Umezawa E, Shimizu T, Yoshimoto Y. Detection of compression vessels in trigeminal neuralgia by surface-rendering three-dimensional reconstruction of 1.5- and 3.0-T magnetic resonance imaging. World Neurosurg 2013; 80:378–385.
  21. Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M, Di Stefano G, Donnet A, et al. European academy of neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26(6):831–4.
  22. Willsey MS, Collins KL, Conrad EC, Chubb HA, Patil PG. Diffusion tensor imaging reveals microstructural differences between subtypes of trigeminal neuralgia. J Neurosurg. 2019 Jul 19:1-7.
  23. Leal PRL, Roch J, Hermier M, Berthezene Y, Sindou M. Diffusion tensor imaging abnormalities of the trigeminal nerve root in patients with classical trigeminal neuralgia: a pre- and postoperative comparative study 4 years after microvascular decompression. Acta Neurochir (Wien). 2019 May 2. doi: 10)1007/s00701-019-03913-5. [Epub ahead of print] PubMed PMID: 31049710.
  24. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ. BMJ Publishing Group; 1995; 311:1047–52.
  25. Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ. 2014;348: g474–4.
  26. Obermann Mark: Treatment Options in trigeminal neuralgia: Ther Adv Neural Disord (2010) 3(2) 107- 115
  27. Al-Quliti KW. Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options. Neurosciences (Riyadh). Medical Services Division, Ministry of Defense; 2015; 20:107–14.
  28. Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. Trigeminal neuralgia – diagnosis and treatment. Cephalalgia. 2017; 37:648–57.
  29. Lunardi G, Leandri M,AlbanoC, Cultrera S, Fracassi M, RubinoV, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. 1997; 48:1714–7.
  30. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo-controlled crossover trial. Pain. 1997; 73:223–30.
  31. Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain. In: Wiffen PJ, editor. Cochrane Database Syst Rev. Chichester: John Wiley & Sons, Ltd; 2007. p. CD006044.
  32. Al-Quliti KW. Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options. Neurosciences (Riyadh). Medical Services Division, Ministry of Defence; 2015; 20:107–14.
  33. Poa Ta Patrick Chieu, et al. Efficacy of Gabapentin in the treatment of trigeminal neuralgia: A systematic review of randomized controlled trials: J Investig Clin Dent. 2019 Nov;10(4): e12448
  34. Cheshire WP Jr. Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J Pain. 2002;3(2):137‐142.
  35. Debta FM, Ghom AG, Shah JS, Debta P. A comparative study between oxcarbazepine and gabapentin regarding therapeutic efficiency and tolerability in the treatment of trigeminal neuralgia. J Indian Acad Oral Med Radiol. 2010;22(1):10‐17.
  36. Lemos L, Flores S, Oliveira P, Almeida A. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain. 2008;24(1):64‐75. https ://doi.org/10. 1097/AJP.0b013 e3181 58011a
  37. Obermann, M., Yoon, M.S., Sensen, K., Maschke, M., Diener, H.C. and Katsarava, Z. (2008) Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 28: 174_181.
  38. Domingues, R.B., Kuster, G.W. and Aquino, C.C. Treatment of trigeminal neuralgia with low doses of topiramate. Arq Neuropsiquiatr 2007 ;65: 792_794.
  39. Jorns, T.P., Johnston, A. and Zakrzewska, J.M. (2009) Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J Neurol 16: 740_744.
  40. Park, J., & Park, H. J. (2017). Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel), 9(9), 260. https ://doi.org/10.3390/toxins 9090260
  41. Cui, M., Khanijou, S., Rubino, J., & Aoki, K. R. (2004). Subcutaneous administration of botulinum toxin A reduces formalin‐induced pain. Pain, 107(1–2), 125–133. https ://doi.org/10.1016/j.pain.2003.10.008
  42. Jianngshan Wei,Xiangyu Zhu, Guan Yang, et al. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta analysis of randomized controlled trials.Brain and Behaviour.2019;00:e01409.
  43. Spatz, A.L., Zakrzewska, J.M. and Kay, E.J. (2007) Decision analysis of medical and surgical treatments for trigeminal neuralgia: how patient evaluations of benefits and risks affect the utility of treatment decisions. Pain 131: 302_310.
  44. Zacest AC, Magill ST, Miller J, Burchiel KJ. Preoperative magnetic resonance imaging in Type 2 trigeminal neuralgia. J NEUROSURG. 2010; 113:511-515.
  45. Ko AL, Ozpinar A, Lee A, Raslan AM, McCartney S, Burchiel KJ. Long-term efficacy and safety of internal neurolysis for trigeminal neuralgia without neurovascular compression. J Neurosurg. 2015; 122:1048–57.
  46. Tronnier VM, Rasche D, Hamer J, Kienle AL, Kunze S. Treatment of idiopathic trigeminal neuralgia: comparison of long-term outcome after radiofrequency rhizotomy and microvascular decompression. Neurosurgery. 2001; 48:1261–8.
  47. Barker FG 2nd, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med.1996;334(17):1077–83.
  48. Gronseth, G., Cruccu, G., Alksne, J., Argoff, C., Brainin, M., Burchiel, K. et al. (2008)Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (anevidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 71: 1183_1190.
  49. Zacest AC, Magill ST, Miller J, Burchiel KJ. Preoperative magnetic resonance imaging in type 2 trigeminal neuralgia. J Neurosurg. 2010;113(3):511–5.
  50. Sandell T, Ringstad GA, Eide PK. Usefulness of the endoscope in microvascular decompression for trigeminal neuralgia and MRI-based prediction of the need for endoscopy. Acta Neurochir (Wien) 2014;156(10):1901–1909.
  51. Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F. Advances in diagnosis and treatment of trigeminal neuralgia. Ther Clin Risk Manag. 2015; 11:289–99 A review of advances in management of TN.
  52. Kim Sup Kang, Lee Hyun Sung, et al. A novel method of locating foramen ovale for percutaneous approaches to the trigeminal ganglion: Pain Physician 2019; 22: E345-E350.
  53. Baabor MG, Perez-Limonte L. Percutaneous balloon compression of the Gasserian ganglion for the treatment of trigeminal neuralgia: personal experience of 206 patients. Acta Neurochir Suppl. 2011; 108:251–4.
  54. Slettebø H, Hirschberg H, Lindegaard KF. Long-term results after percutaneous retrogasserian glycerol rhizotomy in patients with trigeminal neuralgia. Acta Neurochir. 1993; 122:231–5.
  55. Zheng Shuyue, et al. Factors associated with long term risk of recurrence after percutaneous radiofrequency thermocoagulation of the gasserian ganglion for patients with trigeminal neuralgia: A multicenter retrospective analysis: The Clinical Journal of Pain Publish Ahead of Print: 2019 Dec; 35(12): 958-966.
  56. Ran B, Wei J, Zhong Q, Fu M, Yang J, Chen X, et al. Long-term Follow-up of Patients Treated with Percutaneous Radiofrequency Thermocoagulation via the Foramen Rotundum for Isolated Maxillary Nerve Idiopathic Trigeminal Neuralgia. PAIN MED. 2019.
  57. Huang Q, Liu X, Chen J, Bao C, Liu D, Fang Z, et al. The Effectiveness and Safety of Thermocoagulation Radiofrequency Treatment of the Ophthalmic Division (V1) and/or Maxillary (V2) and Mandibular (V3) Division in Idiopathic Trigeminal Neuralgia: An Observational Study. PAIN PHYSICIAN. 2016;19: E1041-E1047.
  58. Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F. Advances in diagnosis and treatment of trigeminal neuralgia. Ther Clin Risk Manag. 2015; 11:289–99 A review of advances in management of TN.
  59. Young RF, Vermulen S, Posewitz A. Gamma knife radiosurgery for the treatment of trigeminal neuralgia. Stereotact Funct Neurosurg. 1998;70(suppl 1):192–199.
  60. Levy R, Deer TR, Henderson J. Intracranial neurostimulation for pain control: a review. Pain Phisician. 2010;13(2):157–165.
  61. Buchanan RJ, Darrow D, Monsivais D, Nadasdy Z, Gjini K. Motor cortex stimulation for neuropathic pain syndromes: a case series experience. Neuroreport. 2014;25(9):715–717.
  62. Broggi G, Franzini A, Leone M, Bussone G. Update on neurosurgical treatment of chronic trigeminal autonomic cephalalgias and atypical facial pain with deep brain stimulation of posterior hypothalamus: results and comments. Neurol Sci. 2007;28(suppl 2): S138–S145.
  63. Rasche D, Rinaldi PC, Young RF, Tronnier VM. Deep brain stimulation for the treatment of various chronic pain syndromes. Neurosurg Focus. 2006;21(6): E8.
  64. Franzini A, Marras C, Tringali G, et al. Chronic high frequency stimulation of the posteromedial hypothalamus in facial pain syndromes and behaviour disorders. Acta Neurochir Suppl. 2007;97(pt 2):399–406.
  65. Cordella R, Franzini A, La Mantia L, Marras C, Erbetta A, Broggi G. Hypothalamic stimulation for trigeminal neuralgia in multiple sclerosis patients: efficacy on the paroxysmal ophthalmic pain. Mult Scler. 2009;15(11):1322–1328.
  66. Franzini A, Ferroli P, Leone M, Broggi G. Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery. 2003;52(5):1095–1099. discussion 1101.
  67. Abd-Elsayed AA, Grandhi R, Sachdeva H. Effective management of trigeminal neuralgia by neurostimulation. Ochsner J Ochsner Clinic, L.L.C. and Alton Ochsner Medical Foundation. 2015; 15:193–5.
  68. Khedr, E.M., Kotb, H., Kamel, N.F., Ahmed, M.A., Sadek, R. and Rothwell, J.C. (2005) Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 76: 833_838.
  69. Lefaucheur, J.P., Drouot, X., Menard-Lefaucheur, I., Zerah, F., Bendib, B., Cesaro, P. et al. (2004) Neurogenic pain relief by repetitive transcranial magnetic cortical stimulation depends on the origin and the site of pain. J Neurol Neurosurg Psychiatry 75: 612-.616

How to cite

–

Journal

International Journal of Dental Sciences & Research

ISSN

-

Periodicity

Bi-Annual

Leading Research Intensive & Industry Driven University
Study at Leading Research Intensive
& Industry Driven University

University Campus

Desh Bhagat University,
Off to NH-44, Amloh Road, Mandi Gobindgarh,
District Fatehgarh Sahib, Punjab- 147301, India